Stockwinners Market Radar for July 29, 2020 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:20 EDT Samsung says Q2 memory demand stayed solid - In Semiconductor segment, Samsung says Memory demand stayed solid from data centers and PC amid weak mobile demand as a result of the COVID-19 continuation, with the second half outlook forecasting mobile/graphic demand to recover backed by launches of new smartphones and game consoles. In Display Panel segment, Mobile revenue improved on a one-off gain despite weaker smartphone demand mainly in developed markets. In IT & Mobile Communications segment, Samsung says smartphone shipments and revenue fell sequentially in Q2 due to store closures and with 5G investment being delayed due to COVID-19. In the second half, Samsung sees the market showing a gradual demand recovery, though "intense competition" is likely to make up for a weak first half performance. Reference Link

19:56 EDT SPDR Gold Shares holdings fall to 1,241.96MY from 1,243.12MT - This is the first decline in holdings since July 9th.

18:28 EDT Altus Midstream sees higher volumes, EBITDA contributions from Shin Oak in Q3 - "We expect higher volumes and EBITDA contributions from Shin Oak during the third quarter as production activity across the basin resumes and margins remain favorable for producers to recover and ship ethane," Bretches added.

18:16 EDT MGM Resorts names William Hornbuckle as CEO - The MGM Resorts board announced that William Hornbuckle has been elected as CEO, effective immediately. Hornbuckle has been serving the company as Acting CEO and President since March 2020. He succeeds former Chairman and CEO Jim Murren, who stepped down earlier this year. Hornbuckle was also appointed to serve on the company's board effective immediately.

17:48 EDT Hubbell consolidating electrical segments to Hubbell Electrical Solutions - Hubbell is consolidating its Electrical segment from three business groups to a single operating group, Hubbell Electrical Solutions. Hubbell Electrical Solutions combines Hubbell's Commercial & Industrial group, Construction & Energy group, and Lighting group into a unified operating group which complements Hubbell's other operating group, Hubbell Utility Solutions. Hubbell has appointed Peter Lau as the new President of Hubbell Electrical Solutions. Lau will join Hubbell in August. He will report to CEO Bakker and will lead the consolidation of the newly formed Hubbell Electrical Solutions. Lau comes most recently from Honeywell where he led the Security and Fire divisions. Concurrently, Hubbell has promoted Rodd Ruland, former Group President of Hubbell's Construction and Energy group to Executive VP, Transition and Integration. In this newly created role, Ruland will continue to report to Bakker, but is tasked with supporting Hubbell's transition into its new operating structure. Ruland has been with Hubbell since its acquisition of Burndy in 2009.

17:40 EDT Crowdstrike Chairman Watzinger sells pver $3M in company shares - Crowdstrike Chairman Gerhard Watzinger disclosed that he had sold 30,000 shares at $103.09 per share on July 27. The total transaction value of the sale was $3,092,72.

17:26 EDT Cheesecake Factory says continues to perform well in the delivery category - Says leveraging the foothold in the off-premise channel to support the business in the COVID-19 environment. Says off-premise sales have contributed to 50% of all revenue quarter to date. Says there is potential for 200 North Italia domestic locations over time. Sees $5M-$10M of growth capital expenditures per quarter to finish construction projects. Comments taken from Q2 earnings conference call.

17:22 EDT Agnico Eagle raises 2020 gold production to 1.68M-1.73M oz. from 1.63M-1.73M - Anticipates total cash costs per ounce and AISC per ounce for 2020 will continue to be in the range of $740 to $790 and $1,025 and $1,075, respectively. Anticipates gold production to average approximately 480,000-500,000 ounces per quarter in the second half of 2020. As a result, total cash costs per ounce are expected to be significantly lower at $690 to $740 per ounce in the second half of 2020. Previous gold production guidance for 2021 and 2022 remains unchanged with a mid-point of 2.05 million and 2.10 million ounces, respectively.The company anticipates the overall effective tax rate to be in the range of approximately 45% to 50% for the second half of 2020 considering current margins. As previously announced, the company anticipates the overall full year effective tax rate to be approximately 40% to 45%.

17:14 EDT Visa urges Class A stockholders to reject Ponos' mini-tender offer - Visa has been notified of an unsolicited "mini-tender offer" by Ponos Industries LLC to purchase up to 1 million shares of its Class A common stock, representing approximately 0.06% of Visa's outstanding shares of Class A common stock. Ponos' offer price of $210.00 is 9.06% above the closing price of Visa's Class A common stock on July 10, 2020, the last trading day prior to the date of the offer. While this price is presently above the current market price of Visa's Class A common stock, the offer is subject to numerous conditions, including that (i) Ponos has obtained sufficient financing to consummate the offer and (ii) the closing price of Visa's Class A common stock on the last day of trading prior to the offer's expiration date exceeds the $210.00 offer price. Unless Ponos waives this condition, Visa stockholders who tender their shares in the offer will receive a below-market price. Visa cautions stockholders that Ponos can extend the offer for successive periods of 45 to 180 days, in which case payment would be delayed beyond the scheduled expiration date of August 15, 2020. There is no guarantee the conditions of the offer will be satisfied. Visa recommends stockholders do not tender their shares in response to this unsolicited mini-tender offer. Mini-tender offers, such as this one by Ponos, avoid many of the investor protections afforded to larger tender offers, including the filing of disclosure and other tender offer documents with the U.S. Securities and Exchange Commission (SEC) and other procedures mandated by U.S. securities laws.

17:03 EDT Dorman Products not providing FY20 guidance - The company states: "Due to the ongoing uncertainty of the economic environment, it remains difficult to determine the full impact that the pandemic will have on overall demand and Dorman's operations. Therefore, Dorman is not providing guidance for the remainder of fiscal 2020 at this time."

17:01 EDT Just Energy utilizes extension period for filing Q1 financial statements - Just Energy announced that it is utilizing the extension period provided under Ontario Instrument 51-505 - Temporary Exemption from Certain Corporate Finance Requirements with Deadlines during the Period from June 2 to August 31, 2020, and similar extension periods provided for by the Canadian Securities Administrators in the other provinces and territories of Canada, for (i) filing its financial statements comprising its interim financial report, and related management's discussion and analysis for the Company's first quarter of Fiscal 2021 ending June 30, 2020, and (ii) compliance with the delivery requirements of applicable securities laws relating to the First Quarter Fiscal 2021 Filings. Just Energy expects to file the First Quarter Fiscal 2021 Filings on or about August 24, 2020. The Canadian Securities Administrators have announced temporary relief from certain regulatory filings required to be made on or before August 31, 2020. This blanket relief is implemented through Instrument 51-505 and similar orders made in the other provinces and territories of Canada which, in light of COVID-19 and its impact on market participants, provides a 45-day extension for periodic filings normally required to be made by issuers during the period from June 2, 2020 to August 31, 2020.

16:56 EDT First Solar announces COO Philip deJong to retire, other leadership changes - First Solar announced that Philip deJong, COO, has decided to retire from the company, effective April 2021. In addition, First Solar announced a series of senior leadership changes. DeJong will continue to serve as COO for an eight-month transition period, during which he will oversee certain priority projects, while transitioning the majority of his responsibilities to Michael Koralewski, chief manufacturing operations officer; Kuntal Kumar Verma, chief manufacturing engineering officer; and Patrick Buehler, chief quality and reliability officer, each of whom will join First Solar's executive leadership team. First Solar also announced that Markus Gloeckler has been appointed co-CTO alongside Raffi Garabedian, First Solar's CTO since 2012, as part of First Solar's new co-CTO structure. Gloeckler will join First Solar's executive leadership team. In addition, First Solar announced that Jason Dymbort will join the executive leadership team as general counsel and secretary after serving in this capacity on an interim basis since March. During his time at First Solar, which began in 2008, Dymbort has held numerous legal roles for the company.

16:48 EDT Service Corp. jumps 12% to $46.00 after Q2 results, FY20 guidance beat estimates

16:47 EDT Cognizant jumps 6% to $69.00 after Q2 results beat estimates, CFO change

16:41 EDT Yum China reaches milestone of 10,000 stores - Yum China announced that it has reached the milestone of 10,000 stores in its restaurant network across China and overseas. It celebrated at the 10,000th store opening this month in Bo'ao, Hainan province. This represents a significant milestone for Yum China which, having first entered China in 1987, has since grown to become the largest restaurant company in the country in terms of system sales. Despite the challenges caused by COVID-19, the company's original target of 800-850 new stores in 2020 remains unchanged.

16:36 EDT Yum China says more than 99% of stores in China are now open - Second quarter operations improved since the COVID-19 outbreak. More than 99% of stores in China are now open, with sales and profits trending unevenly. Sales improved sequentially in April and May but softened in June. Sales were primarily impacted by significantly reduced traffic at transportation and tourist locations, delayed and shortened school holidays and resurging regional infections. These factors and the lingering effect of COVID-19 continue to impact operations in July. The unevenness in recovery was most pronounced in the differences between regions and trade zones. Eastern China recovered faster than other regions. Northern China's recovery was notably slower, primarily due to more stringent public health measures. Transportation and tourist locations, which accounted for high single digits of sales, continue to experience significant year over year traffic declines. The pace of recovery also varies across days of the week. Weekdays recovered the fastest as people returned to work and school, followed by weekends, with holidays lagging behind. The Company's primary focus continues to be safety, efficiency and driving traffic. The Company drove traffic during the second quarter by leveraging its digital and operating capabilities and adapting to changing consumer demand. While dine-in improved when compared to the beginning of the COVID-19 outbreak, delivery and takeaway continued to grow year over year and contributed over half of Company sales in the second quarter. Member sales also grew double digits year over year and exceeded 60% of system sales. Digital ordering grew in popularity, accounting for approximately 80% of Company sales in the quarter. Sales deleveraging and additional costs reduced restaurant margin and operating profit compared to the prior year period. Those negative impacts were partially offset by the realignment of our cost structure and labor productivity improvements. The Company also received one-time relief from landlords and government agencies.

16:34 EDT Yum China: COVID-19 to continue to have 'material and extended adverse impact' - "The company believes that the COVID-19 outbreak will continue to have a material and extended adverse impact on its operational and financial results in 2020. Future operations, as well as the company's cash flows and financial position, may be materially and adversely influenced by further developments related to this global outbreak, including potential additional announcements and actions from governments and local authorities, disruption in our supply chain, our inability to provide safety measures to protect our employees, or other reasons. Nevertheless, the company is well-positioned to capture future growth opportunities through its resilient business model, strong capabilities and dedicated team."

16:32 EDT PTC's Windchill SaaS selected by U.S. Navy - PTC announced that the U.S. Navy has selected PTC's Windchill product lifecycle management Software as a Service offering to support its Model Based Product Support digital transformation initiatives, which is aimed at improving the Navy's operational readiness. The project, launching in PTC's fourth fiscal quarter, will enable the U.S. Navy to unify legacy systems and a myriad of repositories, and, ultimately, to support more than fifteen thousand users, an expansive supplier network, and a vast fleet of ships and submarines. Following an extensive evaluation process, the Naval Sea Systems Command, a branch of the U.S. Navy, selected Windchill over a broad range of other solutions. Key determinants in NAVSEA's selection included the technological prowess, certified cloud infrastructure, powerful collaboration capabilities, and comprehensive workflow of the Windchill SaaS solution.

16:31 EDT Yum China reports Q2 total system sales declined 4% year over year - Total system sales declined 4% year over year, with declines of 6% at KFC and 12% at Pizza Hut, excluding F/X (7% decline excluding the consolidation of Huang Ji Huang).

16:30 EDT Yum China reports Q2 SSS down 11% - Same-store sales declined 11% year over year, with a 10% decline at KFC and 12% decline at Pizza Hut, excluding F/X.

16:26 EDT Trinseo taking actions to reduce operating costs, maximize liquidity - Commenting on the outlook for the remainder of 2020, Bozich said, "As the second quarter progressed we saw improved demand across many of the applications we serve, and so far in the third quarter we are seeing this momentum continue. While we are seeing significant improvement, the rate of recovery remains unknown. Regardless, we've taken actions to reduce operating costs and maximize liquidity and we will continue to manage this closely given the market uncertainty. In addition, we will continue to invest in the higher growth applications we previously outlined - CASE, Engineered Materials, and SSBR - so that we are better positioned to accelerate growth and cash generation."

16:24 EDT Selective Insurance sees 2020 combined ratio 90%-91% - Selective Insurance sees 2020 GAAP combined ratio, excluding catastrophe losses, of between 90% and 91%. This represents an improvement from Q1 guidance, which was between 92% and 93%. Catastrophe losses of 6.0 points on the combined ratio, reflecting higher than expected losses through the first half of the year. As COVID-19 has not been designated a catastrophe event by the Insurance Services Office's Property Claims Services unit, such losses are not included in this ratio; after-tax net investment income of approximately $170M, a $10M improvement from Q1 guidance of $160M. Now expects up to $5M in after-tax net investment income from alternative investments; an overall effective tax rate of approximately 18.5%, which includes an effective tax rate of 18.5% for net investment income, reflecting a tax rate of 5.25% for tax-advantaged municipal bonds and a tax rate of 21% for all other items; and weighted average shares of 60.5 million on a diluted basis.

16:24 EDT AvalonBay authorizes up to $500M stock buyback - AvalonBay announced that its Board of Directors approved a new stock repurchase program under which the Company may acquire shares of its common stock in open market or negotiated transactions up to an aggregate purchase price of $500,000,000. This authority may be exercised from time to time in the Company's discretion and in such amounts as market conditions warrant. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements, market conditions and other corporate liquidity requirements and priorities. The stock repurchase program does not have an expiration date and may be suspended or terminated at any time without prior notice. The Company intends that funds used for the stock repurchase program will be matched over time with the proceeds from sales of existing apartment communities and in some cases with newly issued debt, but initially may be funded from existing cash balances, retained cash flow and/or the Company's line of credit. There have been no stock repurchases under this program through the date of this release.

16:23 EDT Merit Medical will not issue guidance due to e COVID-19 - Due to the general uncertainty and rapidly changing global environment related to the COVID-19 pandemic and corresponding economic downturn, Merit's management has concluded that it cannot issue financial guidance for the remainder of 2020.

16:22 EDT Concho Resources maintains FY20 production, capex outlook - The company's full-year 2020 production and capital expenditure expectations are unchanged at 197 MBopd and $1.6 billion, respectively. Controllable costs are forecasted to be approximately $250 million in the third and fourth quarters of 2020, and oil and gas production taxes are forecasted to be 8% to 10% of oil and gas revenues.

16:19 EDT PayPal CEO: Digital payments 'more important and essential' than ever - President and CEO Dan Schulman said: "In the midst of the COVID-19 pandemic, digital payments have become more important and essential than ever. Our record performance in the second quarter - our strongest quarter ever - reaffirms the relevance of PayPal in the unfolding digital future. We're committed to supporting our consumers and merchants as they work to safely navigate this new reality."

16:18 EDT PayPal reinstates, raises FY guidance based on strong momentum

16:17 EDT PayPal reports 21.3M net new active accounts added in Q2

16:16 EDT Cimpress: Recent results have improved significantly from March and early April - The company said: "This has given us the confidence to remove some of the cost constraints that we put in place in March and April, but we will be disciplined in adding these back given the uncertainty of the shape and timing of a sustained full demand recovery. Emphasizing that uncertainty, if our current level of revenue including historical seasonality continued for FY2021 and assuming we do not choose to make material increases in organic growth investment levels beyond our current plans for FY2021, we believe our operating income and adjusted EBITDA should be roughly back to the results we delivered in the trailing-twelve-month period through December 2019, in other words operating income of approximately $226.0 million and adjusted EBITDA of approximately $471.1 million."

16:15 EDT Quest Diagnostics: FDA grants EUA for new laboratory technique - Quest Diagnostics announced that the U.S. FDA has granted emergency use authorization for a new laboratory technique that speeds the process of extracting viral RNA from specimens* and will enable the company to expand its daily capacity of COVID-19 molecular diagnostic tests on behalf of patients in the United States. With the new FDA EUA, five of the company's laboratories in the U.S. may now run this new RNA extraction method, including on pooled specimens. Those laboratories are well situated geographically to address high testing demand in states where the virus has been surging. The labs are in San Juan Capistrano and Valencia, California; Lewisville, Texas; Lenexa, Kansas; Chantilly, Virginia; and Marlborough, Massachusetts. The company currently has the capacity to perform 135,000 COVID-19 molecular diagnostic tests a day. The new method is expected to add an additional 35,000 tests a day in overall capacity over the next several weeks. In addition, the company will be able to use specimen pooling with the new method to increase capacity even further. Consequently, Quest now expects to have the capacity to perform 150,000 tests per day by next week and to continue to build additional capacity beyond that to 185,000 tests per day by Labor Day. Quest expects this innovation will help it to achieve average turnaround times of 1 day for "Priority 1" patients and 2-3 days for all other patients in coming weeks

16:13 EDT Republic Services raises quarterly dividend to 42.5c from 40c per share - The quarterly dividend will be paid on October 15 to shareholders of record on October 1.

16:11 EDT Qualcomm resolves dispute with Huawei, signs new license agreement - In July 2020, Qualcomm entered into a settlement agreement, as well as a new long-term, global patent license agreement with Huawei, including a cross license granting back rights to certain of Huawei's patents, covering sales beginning January 1, 2020. "While we continue to assess the accounting impacts of the agreements, our financial guidance for the fourth quarter of fiscal 2020 includes the following: Estimated QTL revenues for royalties due on sales made by Huawei in the September 2020 quarter; Estimated revenues of approximately $1.8 billion related to amounts due from Huawei under the settlement agreement (which are incremental to amounts previously paid under two interim agreements) and estimated amounts due for the March 2020 and June 2020 quarters under the new global patent license agreement. This amount will be excluded from our Non-GAAP results." Steve Mollenkopf, CEO of Qualcomm said: "As 5G continues to roll out, we are realizing the benefits of the investments we have made in building the most extensive licensing program in mobile and are turning the technical challenges of 5G into leadership opportunities and commercial wins. We delivered earnings above the high end of our range, continued to execute in our product and licensing businesses and entered into a new long-term patent license agreement with Huawei, all of which position us well for the balance of 2020 and beyond."

16:08 EDT Sprouts Farmers Market opens 6 new stores in Q2 - During the second quarter of 2020, Sprouts opened 6 new stores, resulting in a total of 350 stores in 23 states as of June 28, 2020.

15:37 EDT Bloom Energy affirms comments on NextEra Energy Resources relationship - Bloom Energy (BE) today reaffirmed its comments on its relationship with NextEra Energy Resources (NEE) and offered the following comment: "On our last earnings call, we disclosed that NextEra and Bloom had entered into a new business relationship and we described their company as a 'financing partner.' NextEra purchased a six megawatt fuel cell project on Long Island from Bloom. As set forth in our periodic financial reports and consistent with our past practice, Bloom uses the term 'financing partner' to refer to the purchaser of our fuel cells for use by an end consumer. In addition, NextEra contacted us recently to discuss future collaborations, which resulted in our two companies being actively engaged in discussions regarding several future projects. The statements we made on our earnings call were true and accurate in all respects."

14:17 EDT Kandi announces August 18 event for launch of 'America's most affordable' EVs - Kandi America, the U.S. subsidiary of Kandi Technologies Group, announced its formal launch of "the most affordable electric vehicles on the U.S. market," with an initial focus on the Dallas-Fort Worth metroplex. The company also announced a live virtual launch event on August 18 to kick-off pre-sales and allow customers to put a fully-refundable $100 deposit down for models K27 and K23, which will be available for delivery in fourth quarter 2020. Johnny Tai, CEO of Kandi America, said, "At Kandi, we are on a mission to make electric cars accessible for all. With these first two models, we are starting an Auto EVolution that will allow anyone, regardless of their financial status, to afford a reliable, high-tech EV." The K27 is priced at $12,999 after federal tax credits and the K23 is priced at $22,499 after federal tax credits, Kandi stated.

14:00 EDT Microsoft unveils Microsoft Family Safety app - Liat Ben-Zur, Corporate Vice President, Modern Life, Search, and Devices for Microsoft wrote in a blog post earlier: "Today, we are excited to announce that the Microsoft Family Safety app, designed to help you protect your family's digital and physical safety, is starting to rollout today on iOS and Android. Over the past few months, I have been using the preview with my family, and it has been a game-changer! As a kid, my two favorite things to do after school were to ride my bike and play soccer with my neighborhood friends. Nowadays, my kids are always on their devices, whether playing video games with their friends, on social media or learning remotely. Kids have access to more information and endless ways to connect with other people. This can be scary for parents. As a mom, I seek to give my kids the independence to learn and grow whilst ensuring that they are also safe online and in the real world. Today, I am excited to share with you how any family worried about their kids' online safety can benefit from the Microsoft Family Safety app and how it has helped us to create healthier habits for my kids, while also giving my wife and me peace of mind." Here are the top 5 ways my family has benefited from the Microsoft Family Safety app: 1. Use the weekly activity report as a conversation starter.2. Limit screen time for play and make more time for learning. 3. Set healthy boundaries with web and search filters. 4. Get purchase request emails to avoid surprise spending. " Reference Link

13:33 EDT Onconova reaches required number of survival events for INSPIRE trial analysis - Onconova Therapeutics announced that the required number of survival events for the pivotal Phase 3 INSPIRE has been reached. The Company anticipates announcing topline data by the end of the third quarter of 2020. "Consistent with previous guidance for topline data disclosure, we anticipate providing preliminary efficacy and safety data from the pivotal Phase 3 INSPIRE trial during the third quarter of this year," said Steven Fruchtman, M.D., President and CEO. "Onconova is not currently in possession of topline data. However, we estimate the timing of this data readout based on having achieved the required number of survival events, the continued progress for source verification needed for the data set, and our experience in navigating the challenges of conducting clinical trials in the COVID pandemic environment. We plan to disclose the initial topline data results when available, via press release and subsequent conference call, with a full data presentation anticipated at a major medical conference later this year."

12:57 EDT TikTok's CEO calls out Facebook for 'copycat' products in blog post - In a company blog post, Social media firm TikTok's CEO Kevin Mayer,said in part: "Innovation is one of the defining characteristics of a competitive market. The introduction of a successful new product fuels growth and dynamism in any industry. It is unfortunate for creators, brands, and the broader community that it has been years since a company came along and reimagined what a social entertainment platform could be. But TikTok did just that. TikTok brought a unique and intuitive interface. It gave creators easy, powerful tools. It also encouraged the formation of inclusive and meaningful communities. In short, TikTok brought successful competition to the marketplace. This is why I joined the company as CEO earlier this year: to help lead the next generation of creators to connect with their newly energized audience, while bringing fun entertainment to people's lives...At TikTok we welcome competition. We think fair competition makes all of us better. To those who wish to launch competitive products, we say bring it on. Facebook (FB) is even launching another copycat product, Reels (tied to Instagram), after their other copycat Lasso failed quickly. But let's focus our energies on fair and open competition in service of our consumers, rather than maligning attacks by our competitor - namely Facebook - disguised as patriotism and designed to put an end to our very presence in the US." Other popular U.S- based social media companies include Snap (SNAP) and (TWTR). Reference Link

12:45 EDT Total to take $8.1B impairment charge in Q2 on oil price drop - Total announced that given the drop in the oil price in 2020, it decided to revise the price assumptions over the next years and selected the following profile for the Brent price: $35 per barrel in 2020, $40 in 2021, $50 in 2022 and $60B in 2023. As a result of this short-term price revision, Total recognizes in Q2 an exceptional asset impairment charge of $2.6B. In addition, in line with its new Climate Ambition announced on May 5, which aims at carbon neutrality, Total has reviewed its oil assets that can be qualified as stranded," meaning with reserves beyond 20 years and high production costs, whose overall reserves may therefore not be produced by 2050. For impairment calculations, Total's board has decided to take into account only proven reserves, which leads to an additional exceptional asset impairment of $5.5B. Overall, the exceptional asset impairments that will therefore be taken into account in Q2 amount to $8.1B, including $7B on Canadian oil sands assets alone, impacting its gearing ratio by 1.3%. It added, "For the longer term, Total maintains its analysis that the weakness of investments in the hydrocarbon sector since 2015 accentuated by the health and economic crisis of 2020 will result by 2025 in insufficient worldwide production capacities and a rebound in prices. Beyond 2030, given technological developments, particularly in the transportation sector, Total anticipates oil demand will have reached its peak and Brent prices should tend toward the long-term price of 50$/b, in line with the IEA SDS scenario." Reference Link

12:29 EDT Trump says will bring 'fairness to Big Tech' if Congress does not - President Donald Trump tweeted: "If Congress doesn't bring fairness to Big Tech, which they should have done years ago, I will do it myself with Executive Orders. In Washington, it has been ALL TALK and NO ACTION for years, and the people of our Country are sick and tired of it!" The tweet comes ahead of the start of a U.S. House of Representatives hearing that will feature Facebook (FB) CEO Mark Zuckerberg, Google's (GOOG) Sundar Pichai, Amazon's (AMZN) Jeff Bezos, and Apple's (AAPL) Tim Cook. Reference Link

12:13 EDT NextEra Energy says not a 'financing partner' of Bloom Energy - NextEra Energy Resources (NEE) President and CEO John Ketchum issued the following statement regarding recent Bloom Energy (BE) disclosures about NextEra Energy Resources: "Yesterday, during a call with financial analysts, an executive of Bloom Energy incorrectly asserted that NextEra Energy Resources was a 'financing partner' of Bloom Energy. We have no such relationship with Bloom Energy. NextEra Energy Resources' relationship with Bloom Energy is limited to a recently acquired small fuel cell with an existing power purchase agreement on Long Island, New York. The opportunity became available to us on attractive terms. Our contractual arrangement with Bloom Energy is limited to receiving operational and technology support for this one system. We have no plans to engage in further business activities with Bloom Energy."

12:01 EDT L Brands rises 34.6% - L Brands is up 34.6%, or $6.61 to $25.73.

12:00 EDT Eastman Kodak rises 299.1% - Eastman Kodak is up 299.1%, or $23.75 to $31.69.

11:28 EDT Boeing sees cash consumption improving slightly in 2H20

11:23 EDT Boeing: 737 MAX returning to service would be primary driver for positive FCF - Boeing says the 737 MAX returning to service would be primary driver for positive FCF in 2021.

11:15 EDT CoreLogic comments on Senator/Canne intent to request special meeting - CoreLogic commented on an announcement by two of its shareholders, Senator Investment Group LP and Cannae Holdings Inc., that they intend to request a Special Meeting of Shareholders. This action follows their unsolicited June 26 proposal to acquire all outstanding shares of CoreLogic for $65.00 per share in cash. As previously announced, the CoreLogic Board undertook a thorough review of the acquisition proposal in consultation with its independent financial and legal advisors, and unanimously concluded that it significantly undervalues the Company and is not in the best interests of shareholders other than Senator and Cannae. Chairman Paul Folino said, "The Board continues to believe Senator and Cannae's proposal significantly fails to provide appropriate value to our shareholders and does not reflect our strong multi-year outlook for the business - since their June 26 proposal we have increased our 2020 earnings guidance by more than 15% and issued strong guidance for 2021 and 2022. Our outlook is supported by contracted revenue, continued efficiency improvements and our transformed, less-cyclical business mix, which will be further enhanced by our recently announced planned divestitures of two lower-margin businesses. The proposal also does not account for our substantial return of capital, including a 50% dividend increase and repurchase of $1B of shares by 2022. Further, CoreLogic continues to gain momentum as evidenced by the strong results posted last week in which our organic growth rose to 5%, margins increased by 400 basis points and we achieved record levels of free cash flow. As a result, our Board is unanimous and highly confident in its belief that CoreLogic will be able to deliver significantly more value to shareholders than this opportunistic proposal. We will continue to provide full transparency into our business so all our shareholders can participate in CoreLogic's substantial value creation potential."

11:05 EDT Boeing will further assess size of workforce due to prolonged COVID impact

11:04 EDT Boeing studying feasibility of consolidating 787 production into one location

10:48 EDT Boeing sees growth in COVID cases dampening air travel recovery

10:47 EDT General Motors seeing strong recovery after low point in April

10:46 EDT GM always open to considering anything that will enhance long-term value - When asked if the company would consider a spinoff or other strategic initiatives during the Q&A portion of the Q2 earnings conference call, GM CEO Mary Barra reiterated that management is always open to considering anything that will enhance long-term shareholder value, if it makes sense.

10:39 EDT General Motors not seeing demand slowdown after COVID-19 spikes

10:34 EDT General Motors CEO says 'We believe strongly in our EV business'

10:26 EDT General Motors sees Q3 slightly better than Q4 due to holidays

10:05 EDT Rite Aid opens COVID-19 testing sites in Michigan, Ohio - Rite Aid continues to expand its no-charge COVID-19 testing service with the addition of six drive-through locations opening on July 30 in Michigan and Ohio, through its partnership with the U.S. Department of Health and Human Services. Like Rite Aid's existing drive-through testing sites, the new locations will utilize self-swab nasal tests overseen by Rite Aid pharmacists. Rite Aid's COVID-19 nasal tests are available for all adults, regardless if they are experiencing virus symptoms, in accordance with the Centers for Disease Control and Prevention guidance. Now operating 264 testing sites in 15 states, Rite Aid will have the capacity to conduct more than 96,100 tests weekly across all locations. Rite Aid partners with Verily and its Baseline COVID-19 Testing Program to provide screening, scheduling and return of results to participants for Rite Aid testing sites. BioReference Laboratories provides COVID-19 laboratory testing. Clinical oversight for the COVID-19 testing program is provided by PWNHealth, a national clinician network that enables safe and easy access to diagnostic testing.

10:02 EDT Renewable Energy enters REG Ultra Clean supply agreement with Hunt & Sons - Renewable Energy Group announced the company has entered into an agreement with Hunt & Sons, Inc. to supply REG Ultra Clean at 12 locations in Northern California. REG Ultra Clean is a premium renewable fuel and one of the lowest carbon intensity liquid transportation fuels on the market today which enables businesses to achieve sustainability targets with the performance they expect. REG Ultra Clean will be offered at 12 locations and is currently available at two Hunt & Sons locations: Rancho Cordova and Sacramento.

10:00 EDT Blue Apron falls -16.6% - Blue Apron is down -16.6%, or -$2.34 to $11.74.

10:00 EDT Arlo Technologies rises 29.4% - Arlo Technologies is up 29.4%, or 97c to $4.26.

10:00 EDT Eastman Kodak rises 138.2% - Eastman Kodak is up 138.2%, or $10.97 to $18.91.

09:50 EDT Verastem to start phase 2 study of duvelisib in COVID-19 patients in August - A post to ClinicalTrials.gov indicates that a randomized placebo-controlled phase 2 study, estimated to start in August, will evaluate whether a two-week exposure to Verastem's duvelisib, a gamma/delta phosphoinositide 3-kinase inhibitor, reduces inflammation in the lungs in patients with severe acute respiratory syndrome coronavirus 2 infection and COVID-19 who do not require mechanical ventilation at study initiation. The post, which shows it was last updated on July 28, says the study is not yet recruiting. Reference Link

09:47 EDT Cameco falls -9.7% - Cameco is down -9.7%, or -$1.16 to $10.82.

09:47 EDT Navios Maritime Partners falls -17.3% - Navios Maritime Partners is down -17.3%, or -$1.45 to $6.91.

09:47 EDT Tupperware Brands rises 45.1% - Tupperware Brands is up 45.1%, or $4.34 to $13.97.

09:39 EDT Kodak trading resumes

09:34 EDT Kodak trading halted, volatility trading pause

09:31 EDT Asbury Automotive to acquire Park Place under 'more favorable terms' - Asbury Automotive Group said in its earnings release that entered into a definitive agreement to acquire Park Place Dealerships. "Our focus on gross profit combined with our cost restructuring efforts allowed us to remain pro-active and committed to long term growth by moving forward with acquiring 12 Park Place luxury franchises in the Dallas Fort Worth Market under more favorable terms than the prior agreement. This acquisition will add approximately $1.7 billion in expected annualized revenues and transform our total portfolio to 49% luxury stores. With the addition of Park Place, Asbury will be a stronger, more diversified company," CEO David Hult said.

09:27 EDT CleanSpark awarded $300K contract for Southern California microgrid - CleanSpark has been awarded a contract to provide controls and storage for a commercial microgrid located in Southern California. CleanSpark expects to realize in excess of $300K in initial revenues from the project as well as a long-term software subscription. CleanSpark's patented mPulse controls platform will manage a Battery Energy Storage System paired with photovoltaic rooftop solar panels.

09:22 EDT ClearOne awarded patent for beamforming microphone array technology - ClearOne announced that it has been awarded a significant new patent relating to beamforming microphone array technology by the US Patent and Trademark Office. ClearOne's innovative new patent, US Patent No. 10,728,653, is entitled "Ceiling Tile Microphone." It describes a ceiling tile microphone that includes beamforming, acoustic echo cancellation, and adaptive acoustic processing that automatically adjusts to a room configuration. There is no language in the claims of the new patent limiting its scope to flush-mounted ceiling tile beamforming microphone arrays, as opposed to non-flush mounted ceiling tile beamforming microphone arrays. The '653 Patent is a member of a family of patents and applications that includes US Patent No. 9,813,806. That patent family includes issued patents and patent applications that cover ceiling tile and wall tile embodiments of beamforming microphone arrays, as well as augmentation of beamforming microphone arrays with non-beamforming microphones. The '653 Patent is part of ClearOne's valuable patent portfolio covering new technologies in the fields of audio and video processing, streaming, and innovative communication technologies. ClearOne's patents reinforce and protect its position as a market leader and demonstrate ClearOne's ongoing ability to develop cutting-edge technologies and products.

09:19 EDT Denali Therapeutics announces Sanofi commences dosing DNL758 in Phase 1b study - Denali Therapeutics (DNLI) announced that its partner Sanofi (SNY) has commenced dosing of DNL758, a peripherally-restricted small molecule inhibitor of RIPK1, in a Phase 1b study in hospitalized adult patients with severe COVID-19 lung disease. RIPK1, receptor-interacting serine/threonine-protein kinase 1, is a critical signaling protein in the TNF receptor pathway, which regulates inflammation and cell death in tissues throughout the body. The scientific rationale in treating severe COVID-19 with a RIPK1 inhibitor compound is to attenuate the exaggerated immune response to the SARS-CoV-2 viral infection and thereby limit potential tissue damage resulting from excessive inflammation and aim to improve patient recovery. Denali and Sanofi entered a broad partnership in October 2018 for the global development and commercialization of RIPK1 inhibitors. Beyond COVID-19, the partners are currently investigating DNL788 for CNS indications and DNL758 for peripheral inflammatory indications. Sanofi is responsible for the development and commercialization of DNL758, and covers all costs related to DNL758, and Denali is entitled to receive development and sales milestone payments and royalties on product sales.

09:17 EDT Hanmi Financial reduces quarterly dividend to 8c per share - Hanmi Financial announced that in response to the continued uncertainty surrounding the COVID-19 pandemic, its Board of Directors has reduced its quarterly cash dividend on its common shares for the third quarter to 8c per share. The dividend will be paid on August 31, 2020, to stockholders of record as of the close of business on August 10, 2020. Hanmi believes this dividend reduction is the most prudent course of action at this time as it continues to monitor the Company's financial performance during this pandemic. The Board of Directors will continue to reevaluate quarterly the level of any subsequent regular dividend during this pandemic.

09:15 EDT Cardlytics CAO David Evans to retire - Cardlytics announced that David Evans, chief administrative officer and former chief financial officer, will retire from the Company at the end of the quarter after six years, including four as CFO.

09:14 EDT General Dynamics sees improved revenue in jet unit in Q3, Q4 - Says 'optimistic' about Q3. Comments taken from Q2 earnings conference call.

09:10 EDT CN to invest $25M in Minnesota - CN announced that, as part of its strategic investments to support growing demand and enable supply chains, it plans to invest approximately $25M across Minnesota in 2020. The investments will focus on docks repairs, replacement of rail and ties, maintenance of bridges, level crossings, culverts, signal systems and other track infrastructure.

09:09 EDT Philips launches pre-hospital wireless monitoring solution in the U.S. - Royal Philips announced the launch of its remote monitoring and defibrillator solution for pre-hospital settings in the U.S. The solution is a complete end-to-end system that combines innovative hardware and advanced software to expand the pre-hospital scope of care for first responders. The professional defibrillator is the final element of the overall solution to receive 510(k) clearance from the U.S. Food and Drug Administration and is now available for sale in the U.S. market.

09:07 EDT Ehang 216 obtains SFOC from Transport Canada Civil Aviation - EHang Holdings announced that EHang 216 has obtained a Special Flight Operations Certificate issued by the Transport Canada Civil Aviation, the civil aviation authority in Canada. This is another milestone in regulatory breakthroughs for EHang 216 and the first of this kind permit for periodic operations of passenger-grade AAVs in North America. With the certificate, trial flights of EHang 216 AAVs can be routinely conducted in Quebec province. Last September, EHang was invited to showcase its EHang 216 at the International Civil Aviation Organization's 75th Anniversary ceremony in Quebec, Canada. The EHang 216 AAV was highly appraised by ICAO and many aviation authorities from different countries. This achievement is an important foundation for future urban air mobility operations in Canada.

09:05 EDT Sorrento Therapeutics licenses on-site SARS-CoV-2 test from Columbia University - Sorrento Therapeutics has entered into a licensing agreement with Columbia University for the rights to a rapid, one-step diagnostic test that detects SARS-CoV-2 virus in as little as 30 minutes from a sample of saliva. The test developed by Columbia's team, to be marketed by Sorrento under the COVI-TRACE name, holds all of the testing materials in a single tube and requires no specialized laboratory equipment. The current backlog in SARS-CoV-2 testing has resulted in average turnaround times of between several days to over a week. The COVI-TRACE takes 30 minutes or less to provide a colorimetric reading based on detection of the presence of the virus.

09:03 EDT AMERI Holdings: Jay Pharma to add Dr. Robert Wilkins as Chief Medical Officer - AMERI Holdings announced that its proposed amalgamation partner Jay Pharma has announced the addition of new senior staff as the company prepares to file two new investigational new drug applications for the treatment of radiodermatitis and glioblastoma multiforme. Dr. Robert Wilkins is joining Jay Pharma as Chief Medical Officer. He will begin in the role immediately. In addition to Dr. Wilkins, Jay Pharma is pleased to announce the signing of Dr. Steven Weisman and Innovative Science Solutions Regulatory Services.

09:01 EDT Qualys acquires software assets of Spell Security - Qualys acquired the software assets of Spell Security, an endpoint detection and response start-up. This acquisition aims to strengthen Qualys' security and threat research, advance endpoint behavior detection capabilities, and bring telemetry to the Qualys Cloud Platform. Key Spell Security employees have joined Qualys, including founder Rajesh Mony as CTO, Malware Detection Solutions.

08:57 EDT InveniAI enters strategic AI, ML focused collaboration with GlaxoSmithKline - InveniAI announced a strategic collaboration with GlaxoSmithKline Consumer Healthcare. GlaxoSmithKline Consumer Healthcare will leverage AlphaMeld, an AI and ML platform that empowers internal teams to efficiently evaluate and navigate emerging innovation spanning the Company's key focus areas. The three-year collaboration will grant full access to InveniAI's AI Innovation Lab that encompasses the Consumer Healthcare Module of AlphaMeld and an internal team of cross-functional experts to facilitate accelerated access to innovation.

08:53 EDT Farmer Bros. amends credit agreement, provides business update - Farmer Bros. amended its credit facility with JPMorgan Chase Bank, N.A to increase the Company's flexibility in supporting its current and future business operations as the COVID-19 situation continues to evolve. The Company also provided a business update for the fourth quarter of 2020. As previously reported, the COVID-19 pandemic has had a significant impact on Farmer Brothers' DSD sales network. The Company disclosed on its third quarter fiscal 2020 earnings call that, during the middle weeks of April, sales from the Company's DSD customers declined between 66% to 69% from pre-COVID-19 pandemic average sales. Since that time, the Company saw consistent improvement through early July, with DSD sales currently holding in a range of decline to pre-COVID-19 pandemic average sales of 44% to 47%. Throughout the COVID-19 timeframe, the Company's Direct Ship business has remained relatively stable overall with areas of growth generally offsetting areas of decline. Farmer Brothers has taken swift action to reduce expenses and preserve cash with the goal of operating as efficiently and effectively as possible. As previously announced, on a combined basis, the Company targeted cost-savings actions that would reduce monthly expenses by approximately $6.5 million per month. This goal was exceeded during the fourth fiscal quarter and Farmer Brothers continues to actively manage costs as areas of the business partially return to pre-pandemic sales levels. As of today's date, the Company's total debt was $68.8 million and the Company had cash on hand of $12 million and $21 million of availability on its amended credit facility. As a point of reference, the 2019 fiscal year end reported figure for total debt was $92 million and cash on hand was reported as $7.0 million as of June 30, 2019. Additionally, the Company expects to report lower Accounts Receivable, Accounts Payable and Inventory balances for fiscal year 2020 than were reported for fiscal year 2019/ The Company will provide a more detailed review of its financial results and business when it reports its fiscal year 2020 results in September.

08:47 EDT Open Lending signs Clark County Credit Union to Lenders Protection Program - Open Lending announced that Clark County Credit Union, a $850M institution based in Nevada, has signed with Open Lending to implement the Lenders Protection program. Open Lending's flagship product, Lenders Protection, is a unique auto lending enablement platform. It utilizes proprietary data and advanced decisioning analytics to provide lenders with a powerful way to increase near and non-prime auto loan volumes, without adding significant risk to their auto loan portfolio. Lenders Protection allows auto lenders to model their specific overhead and funding costs and set a target ROA for their insured portfolio. The result is a profitable auto loan portfolio with carefully managed pricing and risk characteristics.

08:45 EDT Delek Logistics appoints Gennifer Kelly to board of directors - Delek Logistics Partners announced the appointment of Gennifer Kelly to the Board of Directors effective July 26, 2020. Kelly previously held the role of Chief Operating Officer and SVP of Western Midstream Partners and Vice President of Marketing for Anadarko Petroleum Corporation.

08:44 EDT Auris Medical completes enrollment in first part of TRAVERS Phase 2 study - Auris Medical Holding announced the completion of patient enrollment into Part A of its Phase 2 "TRAVERS" trial with intranasal betahistine in vertigo. The Company expects to release interim results from TRAVERS and commence Part B of the trial in the coming weeks. In Part A of the TRAVERS trial, three ascending doses of AM-125 or placebo, administered three times daily over a total of four weeks, will be tested in a total of 30 patients. The primary endpoint will be the improvement of vestibular function from baseline to Day 14. This is assessed by measuring for how long patients are able to maintain their balance with eyes closed - once while standing on foam, and once while doing the tandem Romberg test, which requires the two feet to be aligned one after the other. The results from the interim analysis will inform the selection of two doses for further testing against placebo in an estimated 72 patients in Part B of the trial. While the interim analysis will be carried out and prior to starting Part B, open label testing of oral betahistine for reference purposes will be completed.

08:42 EDT SmileDirectClub announces launch of SmileDirectClub Teen - SmileDirectClub announced the launch of its newest product, SmileDirectClub Teen. Designed just for teens, the clear aligner treatment includes SmileDirectClub's new patented aligner case, powered by Tile, featuring a Bluetooth tracker to ensure a teen's aligners are never lost. Available beginning August 4, SmileDirectClub Teen will also include unique new features within SDC's innovative telehealth platform to ensure safe and effective treatment, such as aligner change and doctor check-in notifications for both teens and their parents, lost aligner protection, and more. Teens with mild to moderate malocclusion may get started on their smile journey in two easy ways.

08:40 EDT AnPac Bio completes over 180,000 CDA-based cancer risk assessment tests - AnPac Bio-Medical Science announced it had completed over 180,000 Cancer Differentiation Analysis based tests as of July 15, 2020. AnPac Bio had previously completed more than 169,000 CDA-based tests as of March 31, 2020. From April 1, 2020 to July 15, 2020, the Company completed over 10,000 commercial CDA-based tests and over 1,000 CDA-based tests for research purposes, which increased the cumulative number of CDA-based tests to over 180,000.

08:38 EDT South Jersey Industries releases ESG report - SJI released its Environmental, Social and Governance Report highlighting the company's 2019 efforts and achievements in environmental sustainability, social impact and corporate governance. The new report expands on earlier versions of the report - highlighting the growing program and commitment to ESG initiatives. The fully web-based, mobile-responsive report offers increased transparency and enhanced data disclosures, measuring progress over time, while also addressing timely ESG topics.

08:36 EDT Baxter enters partnership with Ayogo, terms not disclosed - Baxter and Ayogo Health announced the expansion of their partnership to support the needs of patients with kidney disease through digital health solutions. The companies said in a release, "Ayogo is combining LifePlan-its unique behavior-based digital platform-with Baxter's expertise in renal care to build mobile apps and digital solutions that bring personalized, relevant and timely support to patients with kidney failure. Baxter also made an equity investment in Ayogo in exchange for minority interest in the company. Financial details of the agreement were not disclosed."

08:36 EDT Ascot Resources intersects 20.06 g/t gold over 3.23 metres at Premier West - Ascot Resources announced high gold grades in the first seven drill holes of the 2020 season. The drill site is strategically located to the west of the Premier deposit, potentially adding to existing resources outlined in the feasibility study. The significance of this prospective corridor is further highlighted by high gold grades in surface grab samples even further along strike to the west at Hope, Cascade Creek and Woodbine. Highlights of this release include: 20.06g/t Au over 3.23m in hole P19-2193; 9.21g/t Au over 6.00m in hole P19-2183; 16.25g/t Au in a grab sample from Cascade Creek. In early June the Company started drilling on the area west of the Premier open pit. Mineralization occurs in several areas at surface over a strike length of nearly 2 kilometres, namely at the Premier mill road, the Hope zone at the Granduc road, the Cascade Creek valley and the Woodbine prospect. Ascot designed a drill program to explore the area west of the Premier mineralization in sufficiently tight spacing to potentially add to the resources in this area. To that end, six fences of drill holes were designed from one strategically positioned pad for the systematic step outs. To date four fences of holes have been completed and this release summarizes the results from the first seven drill holes on fence one and two. Drilling of the remaining holes is continuing with samples already in the laboratory for analysis. Drill hole results are slower than anticipated due to Covid protocols at the lab.

08:33 EDT Vishay says Analog Devices approves Alpha Electronics RWB series resistors - VPG Foil Resistors, a product group of Vishay Precision Group, Inc. (VPG), announced that Analog Devices (ADI) has approved Alpha Electronics RWB100R0AL and RWB2K000AL Bulk Metal Foil technology resistors for use with their new AD74413R integrated circuit solution. The AD74413R is a quad-channel software configurable input/output solution for building and process control applications. Analog Devices noted that the outstanding stability and precision of the RWB100R0AL and RWB2K000AL resistors complement the performance and the AD74413R in real world applications. Specifically, the AD74413R datasheet calls for an external 100 'RSENSE' resistor used to measure current output, current input, and RTD values. Analog Devices noted that the accuracy and stability of this resistor directly affect the performance of the circuit. The Alpha Electronics RWB100R0AL resistor was approved by Analog Devices for 'RSENSE' due to its outstanding tolerance of 0.05%, TCR of +/-2 ppm/ degrees C max. and load-life stability of +/-0.005% typical. In addition, an external current limiting resistor of 2 kundefined is required for the SENSEH_x pin. The accuracy of this resistor directly affects the RTD specifications. Analog Devices approved the Alpha Electronics RWB2K000AL for the SENSEH_x resistor due to its tight tolerance of 0.05%, TCR of +/-2 ppm/ degrees C max. and ultra-low capacitance. Made in Japan, the RWA/RWB/RWC Series resistors from Alpha Electronics, a brand of VPG Foil Resistors, feature low TCR of +/-2 ppm/ degrees C and resistance tolerance as low as +/-0.01% in three case sizes: 0603, 0805, and 1206. Produced with Bulk Metal Foil technology, the RWA/RWB/RWC Series devices are optimized for industrial applications that require resistors with extremely tight load-life stability of +/-0.005% typical at 70 degrees C and rated power for 2,000 hours. In these applications, the devices provide superior TCR, long-term stability and pulse handling capability when compared to thin-film resistors.

08:31 EDT Information Services to acquire Paragon for C$70M - Information Services announced that its Services segment, through its wholly-owned subsidiary, ESC Corporate Services has executed a purchase agreement to acquire substantially all of the assets used in the business of Paragon for C$70M, subject to customary purchase price adjustments. Paragon is a technology enabled company whose primary focus is the facilitation and coordination of asset recovery on behalf of many of Canada's regulated major banks. Asset recovery comprises the identification, retrieval and disposition of movable assets such as automobiles, boats, aircraft and other forms of portable physical assets used as collateral security for primarily consumer focused credit transactions. The addition of Paragon's assets is expected to strengthen ESC's current offering and means that ESC will be able to offer its clients a complete solution in the credit life cycle, from origination to recovery. This acquisition is consistent with ISC's long-term strategy of acquiring companies with competencies or operations in its industry space. The Company's Services segment is positioned to support the growing needs of financial institutions and legal firms to outsource key business processes associated with credit due diligence, protection and asset recovery solutions while they focus on their core businesses. Subject to certain customary closing conditions, the transaction is expected to close on or about July 31, 2020. The C$70M purchase price will be paid in cash drawing upon ISC's credit facility. While management is satisfied with its ability to continue to fund operations through operating cash flow, the Company is working with its banking partners to increase the current credit facility. ISC has already agreed on key parameters with its lead bank and is working with a syndicate to finalize changes to the existing credit facilities.

08:27 EDT Madison Dearborn to acquire IPL Plastics for C$10.00 per share in cash - IPL Plastics announced that it has entered into an arrangement agreement to be acquired by Intelligent Packaging Limited Purchaser, an entity controlled by funds managed by Madison Dearborn Partners, a Chicago-based private equity firm. Under the terms of the Arrangement Agreement, subject to shareholder and other customary approvals, the Purchaser will acquire at C$10.00 in cash per share all of the issued and outstanding common shares (the "Shares") of IPLP. The Purchase Price represents a 49% premium to the IPLP closing share price on July 28, 2020, a 69% premium to the 20-day volume-weighted average price per share for the period ending on July 28, 2020, and a 153% premium to the closing price on May 15, 2020, the last trading day prior to media reports concerning a potential acquisition. The transaction values IPLP at C$555 million on an equity basis and at C$981 million on an enterprise basis. Entry into the Arrangement Agreement was based on the unanimous recommendations of both the IPLP board of directors and the independent committee of the Board and followed an extensive review and analysis. The majority of the outstanding Shares owned by Caisse de depot et placement du Quebec, the largest shareholder of IPLP, are effectively to be rolled over at an implied value per Share equal to the Purchase Price, such that upon completion of the transaction, the MDP Funds will be the controlling shareholder of IPLP, with a wholly-owned subsidiary of CDPQ holding a minority equity interest of approximately 24.9%. The remaining Shares owned by CDPQ will be sold to the Purchaser at the Purchase Price. CDPQ plans to continue to support the development of the Company in Quebec and abroad. Provided that it maintains a minimum ownership threshold, CDPQ will hold governance rights in respect of material modifications to certain Company activities in Quebec. Under the terms of the Arrangement Agreement, IPLP may solicit a superior offer for a defined "go-shop" period, as further outlined below. BMO Nesbitt Burns has been retained to approach potential interested parties with a view to soliciting a higher offer, which the MDP Funds are entitled to match. In response to various confidential enquiries and unsolicited preliminary proposals from North American and European private equity sponsors who wished to explore a potential privatization transaction involving the Company, the Board established the independent Special Committee. PwC has provided the Special Committee with a formal valuation of the Shares of the Company in accordance with MI 61-101, which determined that, as of July 28, 2020, and subject to the assumptions, limitations and qualifications set out in PwC's written valuation report, the fair market value of the Shares ranged between C$9.20 and C$10.90 per Share. PwC has also provided an opinion to the Special Committee that, as of July 28, 2020, and subject to the assumptions, limitations and qualifications set out in PwC's written fairness opinion, the consideration to be received by the selling shareholders of the Company is fair, from a financial point of view, to such shareholders. PwC's formal valuation and fairness opinion were prepared for the sole use of the Special Committee and were one factor, among others, that the Special Committee and the Board considered in determining whether to approve the transaction. BMO Capital Markets, the Company's financial advisor, has also provided the Special Committee and the Board with an opinion that, as of July 28, 2020, and subject to the assumptions, limitations and qualifications set out in BMO Capital Markets' written fairness opinion, the consideration to be received by the selling shareholders of the Company is fair, from a financial point of view, to such shareholders. The formal valuation and both fairness opinions will be made available to shareholders in the Company's information circular for the special meeting of shareholders, which will be filed by the Company under its profile at www.sedar.com. Based upon the factors and considerations described above, the Special Committee and the Board unanimously recommend the Arrangement Agreement be approved by shareholders.

08:27 EDT Leaf Group investor group issues statement on replacing CEO Sean Moriarty - Investors owning over 40% of the issued and outstanding shares of Leaf Group issued the following statement: "We anticipate that the Leaf Group Board of Directors (the "Board") will likely be meeting today in advance of releasing Q2 earnings results tomorrow. The agenda for this meeting must include a frank and objective discussion of Sean Moriarty's dismal performance during his tenure, now approaching six years as CEO. If the Board does not conclude at this meeting that Mr. Moriarty should be replaced, shareholders will know that the incumbent directors place their own interests and relationship with Mr. Moriarty ahead of the expressed wishes of shareholders. To be clear, any half measures - such as appointing new board members or launching a process to do so - will not satisfy us. We strongly caution the Board against installing new directors without significant input from major shareholders. With holders of a majority of the stock publicly advocating for significant change, the Board has absolutely no mandate to self-refresh. Further, any Board 'refreshment' rubber stamped by a third-party recruiting firm would have no more inherent credibility than the Company's sham strategic review process. At this point, the only third parties the Board should be paying attention to are the Company's shareholders. In that vein, we are dismayed that we have heard only once in the past three weeks from the so-called Independent Committee of Directors (the "Committee"), consisting of Beverly Carmichael and Deborah Benton, that was supposedly assembled to engage with us. In that one conversation, we were highly disappointed to learn that Mr. Moriarty had the Board's 'full support' despite the calls for his removal (at that time) from 40% of the Company's shareholders. In the days since that one conversation with the Committee, several additional shareholders have come forward - today, we know of nearly 60% of the Company's shareholders that have expressed their view, publicly or privately to the company, that significant change at the Company is necessary. If the Committee and the Board are unwilling to demonstrate that their position has evolved in response to this mounting opposition to the status quo, then they cannot credibly claim that they are upholding their fiduciary duties in good faith. The Board must decide at its next meeting whether the directors stand with shareholders - and the facts - or instead with Mr. Moriarty. This is not a hard choice, but it does require leadership. We urge the Board to do right by shareholders, including terminating CEO Sean Moriarty and working towards a solution that includes new, independent directors selected in conjunction with a majority of shareholders and a fresh strategic review process."

08:22 EDT Denbury Resources enters restructuring support agreement for pre-packaged plan - Denbury Resources announced that it has entered into a Restructuring Support Agreement with funded debtholders holding 100% of revolving credit facility loans, approximately 67.2% of second lien notes and approximately 70.8% of convertible notes for a "pre-packaged" plan that will eliminate the Company's $2.1B of bond debt. To implement the balance sheet restructuring contemplated by the RSA, the Company is soliciting approval of the "pre-packaged" plan and expects to file voluntary petitions for reorganization under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the Southern District of Texas on or before July 30, 2020. Denbury expects to continue normal operations throughout the Court-supervised process. Pursuant to their commitment letter, the Company's existing lenders will provide a debtor-in-possession revolving loan that will "roll" into an exit facility with up to $615M in availability. Following Court approval, the Company expects this financing, together with cash flow from operations, to support the business during the Court-supervised process. Denbury will continue to evaluate the operating environment and make adjustments, as necessary, to adapt to the impact of COVID-19, OPEC+ actions and other factors affecting its business. The Company intends to seek Court approval to pay suppliers in full under normal terms for goods and services provided on or after the filing date. Under terms of the "pre-packaged" plan, which is subject to Court approval, general unsecured pre-petition claims will also be paid in full in the ordinary course.

08:20 EDT CV Sciences launches CV Acute, new immunity product line - CV Sciences announced a strategic category expansion into condition specific dietary supplements with the launch of CV Acute, the first of several products to be launched under its new Immunity product line. This new non-CBD product line will open markets and sales channels for the Company, including major e-commerce retailers not currently accessible by CBD-based products. CV Acute is a clinically researched, wide-spectrum, proprietary plant-based formula to support immune system and respiratory health. CV Acute integrates a time tested Traditional Chinese Medicine herbal formula with proprietary modern analytical chemistry and extraction techniques2. The formula is supported by global medical authorities and hundreds of published scientific studies that demonstrate overall immune system defense to everyday challenges with enhanced support for respiratory health.

08:20 EDT Cannae, Senator propose nine independent directors for CoreLogic board - Cannae Holdings and Senator Investment Group, LP, which, directly or through affiliated entities, jointly own or have an economic interest equivalent to approximately 15% of the outstanding shares of CoreLogic, issued an open letter to fellow shareholders. In the letter, Cannae and Senator announce that they have initiated the process to call a special meeting of shareholders to elect nine independent directors to the CoreLogic Board of Directors. Cannae and Senator said in the letter: "We will seek to replace a majority, but not the entirety, of the Board. This will not be a vote to sell the Company to us for $65 per share. Rather, it will be a vote to put in place these nine independent directors who will act in the best interest of all shareholders... We appreciate the widespread shareholder support we have received. As we stated in our June 26th letter, we expect that we would be able sign a definitive merger agreement and announce the transaction within one month after the Company provides due diligence access and believe that, once signed, we will be able to consummate the transaction within two to three months. Calling a Special Meeting to replace directors introduces delay and is a suboptimal outcome for all."

08:17 EDT General Electric will continue to look for ways to cut costs, preserve cash

08:13 EDT BioTelemetry acquires On.Demand platform from Centene subsidiary - BioTelemetry (BEAT) announced it has acquired the On.Demand remote patient monitoring and coaching platform, operated by Envolve People Care, Inc., a Centene (CNC) Corporation subsidiary. This acquisition adds chronic RPM and coaching solutions to BioTelemetry's current suite of acute care connected health products and services, focusing specifically on diabetes, hypertension and chronic heart failure. As part of this acquisition, and under the companies' strategic partnership agreement, BioTelemetry becomes the exclusive provider of diabetes RPM services to Centene Medicaid members currently utilizing, implementing or engaged to implement the platform in 2020. In addition to Centene, BioTelemetry will partner externally with payor, provider and employer organizations to improve health outcomes, reduce costs and eliminate waste using On.Demand's targeted monitoring and coaching interventions. On.Demand is a mHealth solution that combines real-time monitoring of biometric data with cellular- and web-based technology, proactive and reactive health coaching, population health reporting and customizable interventions. The platform is designed to supplement a physician's care plan by increasing patient engagement, improving compliance and reducing costs. It matches people to the clinical expertise and condition management tools they need when they need them, providing intervention and triage that helps bridge the gap between patient visits. In addition, the platform also includes Alexa Skill. On.Demand users are able to schedule coaching appointments, access educational resources, set reminders, and receive real-time assessments and immediate referrals for mental and physical health needs.

08:10 EDT New Age Beverages changes name to NewAge - NewAge announced that it has changed its name to NewAge, Inc. from New Age Beverages Corporation to reflect the strategic priorities of the business and to be representative of the significant opportunities it sees in the broader consumer products goods arena. The change follows the recent announcement to combine with ARIIX and four additional e-commerce and direct selling companies, which will create a global firm with estimated pro forma revenues in excess of $500M across more than 75 countries worldwide. Although NewAge remains committed to the beverage category in all channels, and beverages still represent almost 50% of the Company's portfolio, NewAge sees significant opportunities in the broader consumer goods landscape, leveraging its unique omni-channel route to market, and, in particular, its significant direct and e-commerce presence in major markets around the world.

08:09 EDT Comscore's audience measurement solutions selected by B.A.S.S. - Comscore announced an agreement to provide the Bass Anglers Sportsman Society or B.A.S.S. with Comscore's digital audience and television measurement. The agreement includes Comscore's Media Metrix Multi-Platform, which combines consumers' desktop and mobile behavior with advanced audience information to drive relevant advertising opportunities, as well as custom reporting derived from Comscore's TV Essentials. B.A.S.S. aims to advance sportfishing through advocacy, outreach and an expansive tournament trail while connecting directly with the community of bass anglers through its media vehicles. Comscore Media Metrix Multi-Platform provides an unduplicated view of total audience behavior across desktops, smartphones and tablets.

08:08 EDT Izea awarded multi-national influencer marketing campaign - IZEA Worldwide announced that it has secured a mid six-figure contract with an entertainment company, a division of a Fortune 100 corporation. The contract represents the largest award IZEA has received from this customer to date, following a string of successful influencer marketing campaigns which have generated in excess of ten billion views on social media. IZEA will be executing a large-scale influencer marketing initiative that will include influencers in the United States, Latin America, Asia, and Europe across a variety of social media channels and content formats. In addition to this contract, IZEA was awarded a separate multi-national influencer marketing initiative by a Fortune 500 manufacturing company on the same day. IZEA will be executing a campaign in Europe and Asia for the customer, promoting athletic wear. IZEA has a long history with this client, but this campaign marks the first multi-national initiative IZEA will be executing on their behalf.

08:08 EDT Regulus: FDA grants Orphan Drug Designation to RGLS4326 - Regulus Therapeutics announced that the U.S. FDA has granted Orphan Drug Designation to RGLS4326 for the treatment of patients with ADPKD.

08:06 EDT General Electric remains cautious going into 2H

08:05 EDT GE CEO: Macro environment could deteriorate further before recovering

08:05 EDT Editas Medicine, Catalent enter strategic partnership for gene editing medicine - Editas Medicine (EDIT) and Catalent (CTLT) announced that they have entered into a strategic partnership whereby Catalent will provide support for the development, manufacturing, and clinical supply of Editas Medicine's current and future portfolio of in vivo CRISPR medicines and engineered cell medicines. To date, Catalent has undertaken manufacturing and related services for Editas Medicine at its gene therapy manufacturing facility in Baltimore, Maryland. Through the extended partnership, Catalent will provide further services to include development and manufacturing of Editas Medicine's complex cell and gene medicines from its best-in-class facilities in Harmans/BWI, Maryland, and Houston, Texas. In addition, Catalent will play an integral part in delivering these vital therapies from its Philadelphia facility to clinical trial sites for administration to patients. Catalent's integrated support will range from supplying critical raw materials, viral vectors, and engineered cell medicine production to storage and distribution of finished product for clinical trials. Catalent's cell and gene therapy facilities include the new 32,000 square feet cell therapy clinical facility near Houston, which is expected to be fully validated in 2020, as well as a clinical facility in Gosselies, Belgium, with a dedicated commercial-scale plant currently under construction and expected to be fully commissioned in 2021. The state-of-the-art Harmans/BWI commercial gene therapy manufacturing facility is equipped with single-use technology and includes over 200,000 square feet of late-stage clinical and commercial-stage gene therapy production capabilities. The Harmans/BWI facility is one of Catalent's five clinical through commercial scale gene therapy facilities in Maryland.

08:03 EDT Teva announces Otsuka Pharmaceutical marketing approval submission for Ajovy - Teva announced Otsuka Pharmaceutical has submitted an application to the Pharmaceuticals and Medical Devices Agency of Japan to obtain manufacturing and marketing approval in Japan for Ajovy injection for the preventive treatment of migraine. Ajovy is under development in Japan by Otsuka as part of a May 2017 exclusive license agreement for development and sales of Ajovy in Japan. Earlier this year, the two companies announced outcomes from two pivotal studies of Ajovy in Japan in patients with episodic and chronic migraine. The primary endpoints were achieved in both trials with clinical and statistical significance versus placebo. Statistically significant improvements versus placebo also were demonstrated for all secondary endpoints. Ajovy was well tolerated with a similar adverse events profile compared to placebo.

08:01 EDT Ryder saw $45M pre-tax earnings impact due to COVID-19 in Q2 - Ryder said in its Q2 results, "The COVID-19 pandemic and measures taken to prevent its spread negatively affected Ryder's business for a total estimated pre-tax earnings impact of $45 million in the second quarter, including lower commercial rental demand ($55 million estimated impact) and reduced automotive activity in supply chain ($25 million estimated impact), partially offset by COVID-19-related temporary cost savings of $35 million. In addition, the impact of COVID-19 on current and expected used vehicle market conditions triggered a review of Ryder's residual value estimates, resulting in increased depreciation and valuation adjustments totaling approximately $49 million in the second quarter. Due to the effects of COVID-19, the company now expects the recovery in the used vehicle market will be delayed beyond the company's prior expectation of mid-2021. Although we saw stronger than expected volumes in used vehicle sales in both the retail and wholesale markets, we expect pricing pressure to continue through mid-2022. As a result, the company primarily extended accelerated depreciation on vehicles expected to be sold by an additional year through mid-2022 and lowered long term policy residual value estimates, particularly for trucks. Additionally, in order to address elevated used vehicle inventories, certain vehicles were written down to reflect wholesale pricing levels. The estimated impact of the residual value changes in the second quarter includes $31 million from additional accelerated depreciation and valuation adjustments and $18 million of policy depreciation."

07:59 EDT Boeing expects commercial aviation to revert to growth trend over long-term - Comments taken from Q2 earnings conference call presentation slides.

07:52 EDT Monro completes rollout of Amazon collaboration for tire installation services - Monro, Inc. (MNRO) announced it has completed the rollout of its collaboration with Amazon.com (AMZN) to provide tire installation services at all of its more than 1,200 store locations in 32 states. Monro's tire installation services are now available to customers who purchase tires from Amazon.com and select the Ship-to-Store option at all of Monro's retail stores in each of the 32 states in which it operates.

07:49 EDT Aaron's says Steve Michaels named CEO of Progressive Leasing segment - Steve Michaels, the company's CFO and President of Strategic Operations, has been appointed CEO of the company's Progressive Leasing business segment, effective July 31, succeeding Ryan Woodley. Woodley will serve as an advisor to Progressive to ensure a seamless transition. Blake Wakefield, President and Chief Revenue Officer of the Progressive Leasing business segment, who has been instrumental in the growth of Progressive Leasing and the development of its retail partner portfolio, will continue to serve in that capacity. Both Michaels and Wakefield will continue to serve in their respective capacities following completion of the separation. Also, effective July 31, Douglas Lindsay, President of the company's Aaron's Business segment, will become CEO of the Aaron's Business, and Steve Olsen, COO of the Aaron's Business, will become President of the Aaron's Business. Lindsay and Olsen have been the primary architects of the Aaron's Business transformation, including its merchandising, real estate and technology strategies. Both Lindsay and Olsen will continue to serve in their respective capacities following completion of the separation. John Robinson, President and CEO of Aaron's, will continue in his current role and will oversee the separation. He is expected to depart from his day-to-day role at the company upon the earlier of completing the separation or December 31, 2020 and is expected to serve as Chairman of Aaron's. Ray Robinson, who currently serves as the Company's Chairman, is expected to serve as Chairman of Progressive following the separation. Kelly Wall, Senior Vice President of Finance and Treasurer of Aaron's, will serve as Interim CFO of the company until the separation has been completed.

07:47 EDT Medipharm Labs, Hybrid Pharm partner for same day registration, delivery service - MediPharm Labs announced it will supply premium, pharmaceutical-quality cannabis products to Hybrid Pharm. Partnering with MediPharm Labs as a trusted supplier, Hybrid Pharm is unique among pharmacies in Canada in that it provides medical cannabis patients with a full in-store experience including consultation services. Hybrid Pharm's qualified pharmacists work closely with healthcare practitioners to provide same day registration and delivery, as well as drug interaction checks and continuous care monitoring. Under the renewable one-year agreement, MediPharm Labs will provide its own CBD25:5 Release Formula and CBD50 Plus Formula introduced this spring, as well as special formulations of branded vaporizers to be sold by Hybrid Pharm.

07:46 EDT Gilat Satellite awarded cellular backhaul project for Kcell - Gilat Satellite Networks announces the award of a cellular backhaul project for Kcell, Kazakhstan's largest Mobile Network Operator. Gilat will provide connectivity starting with hundreds of rural villages, in partnership with Kazakhstan's recognized service provider, TelService LTD, to satisfy the "Digital Kazakhstan" government program.

07:44 EDT Aeterna Zentaris receives Nasdaq notification regarding minimum bid price - Aeterna Zentaris announced that on July 27, 2020, the Company received notice from the Listing Qualifications Department of The Nasdaq Stock Market indicating that, based upon a closing bid price of less than $1.00 per share for the Company's common stock for the prior 30 consecutive business day period, the Company no longer satisfies Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided a grace period of 180 calendar days, through January 25, 2021, to evidence compliance with the Rule. To evidence compliance with the Rule, the Company must evidence a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days, but generally not more than 20 consecutive business days, on or before January 25, 2021. In the event the Company does not timely evidence compliance with the Rule, the Company may be eligible for an additional 180-day grace period or may face delisting. In the latter case, the Company would be entitled to request a hearing before the Nasdaq Hearings Panel, which request would stay any delisting action by the Staff pending completion of the hearing process. Nasdaq's notice has no immediate effect on the listing of the Company's common shares on Nasdaq and does not otherwise impact the Company's listing on the Toronto Stock Exchange. The Company is considering the options available to it to evidence compliance with the Rule prior to the expiration of the grace period. In addition, as previously disclosed via Form 6-K filed with the Securities and Exchange Commission on July 1, 2020, Aeterna Zentaris priced an approximate $12M public offering of its common stock and warrants, pursuant to which the Company ultimately raised approximately $10.5M in net proceeds. As a result of the offering, the Company believes it has stockholders' equity of at least $2.5M as of the date of this filing and thereby satisfies the minimum stockholders' equity requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(3). The Company is awaiting Nasdaq's formal confirmation of such compliance and will provide additional disclosure upon receipt of a compliance determination from the Staff.

07:39 EDT Heat Biologics announces preclinical testing of its COVID-19 vaccine - Heat Biologics announced "successful" pre-clinical testing of the company's COVID-19 vaccine, which demonstrated in-vivo confirmation of vaccine immunogenicity in animal models, including expansion of human-HLA-restricted T-cells against immunodominant epitopes of SARS-CoV-2 Spike protein. Testing demonstrated expansion of antibody-supporting CD4+, and virus killing CD8+ T-cells in the lungs of the animals, a major site for COVID-19 infection.

07:39 EDT Monro amends revolving credit facility - On June 11, 2020, Monro reached an agreement to temporarily amend certain financial and restrictive covenants of its current five-year revolving credit facility in order to provide the Company with greater financial flexibility to operate its business.

07:38 EDT Monro completes rollout of Amazon collaboration for tire installation services - The Company announced that it has completed the rollout of its collaboration with Amazon.com to provide tire installation services at all of its 1,247 retail tire and automotive service locations across 32 states. The Company's collaboration with Amazon.com is a key component of its omni-channel strategy to drive improved customer-centric engagement.

07:37 EDT GE to fully monetize Baker Hughes position over three years - General Electric said "concurrent with today's earnings release, GE is launching a program to fully monetize its Baker Hughes position over approximately three years. This program is designed to enable GE to sell its shares at a price that approximates the volume-weighted average price of the Baker Hughes shares over an extended period of time. Executing on this program over time will allow GE to divest a substantial non-core asset, redeploy capital, enhance financial flexibility, and strengthen its balance sheet. GE expects to use proceeds from these transactions for further deleveraging."

07:36 EDT Hess Corp. raises FY20 production view to 330,000 boepd from 320,000 boepd - Net production guidance, excluding Libya, increased to approximately 330,000 boepd, up from the previous guidance of approximately 320,000 boepd. Bakken net production guidance increased to approximately 185,000 boepd, up from the previous guidance of approximately 175,000 boepd due to year to date performance and the deferral of the planned maintenance turnaround at the Tioga Gas Plant from Q3 until 2021.

07:34 EDT General Motors: Adjusted EPS includes 8c gain from PSA revaluations - Reports Q2 EBIT-adjusted of ($0.5B). Reports Q2 automotive liquidity of $30.6B, automotive operating cash flow of $(8.0B), and adjusted automotive free cash flow of $(9.0B).

07:33 EDT Arrowhead earns $20M milestone payment from Amgen for start of Phase 2 trial - Arrowhead Pharmaceuticals (ARWR) announced that it has earned a $20 million milestone payment from Amgen (AMGN) following the administration of the first dose of AMG 890, formerly referred to as ARO-LPA, in a Phase 2 clinical study. Arrowhead said in a release, "The study is evaluating the efficacy, safety, and tolerability of AMG 890 in subjects with elevated levels of lipoprotein (a) (Lp(a)). Emerging research has shown that elevated levels of Lp(a) are strongly associated with cardiovascular disease. AMG 890 is an investigational RNA interference, or RNAi, therapeutic designed to lower Lp(a) for the treatment of cardiovascular disease. The clinical study is a double-blind, randomized, placebo-controlled Phase 2 study to evaluate efficacy, safety, and tolerability of AMG 890 in 240 subjects with elevated Lp(a). The primary outcome measure is the percent change in Lp(a) from baseline to week 36. Secondary outcome measures include the percent change in Lp(a) from baseline to week 48, percent change in low-density lipoprotein cholesterol, or LDL-C, from baseline to weeks 36 and 48, percent change in Apolipoprotein(B) (ApoB) from baseline to weeks 36 and 48, maximum observed concentration, or Cmax, of AMG 890, and area under the concentration-time curve, or AUC. Under the terms of the agreement with Amgen announced in September 2016, Arrowhead is eligible to receive development, regulatory, and sales milestone payments. Arrowhead is further eligible to receive up to low double-digit royalties for sales of products under the AMG 890 agreement."

07:32 EDT General Motors: Q2 results reflect actions to be more resilient

07:31 EDT Boeing reports Q2 total backlog of $409B, including over 4,500 commercial planes

07:26 EDT GlaxoSmithKline guidance for 2020 adjusted EPS maintained - The company previously said it expected full-year 2020 Adjusted EPS to be in a decline in the range of -1% to -4% at CER.

07:24 EDT Accenture subsidiary awarded $328M contract - Accenture Federal Services, a subsidiary of Accenture, has been awarded a contract to support operations, security, and modernization of the technology applications of the U.S. Department of Veterans Affairs Loan Guaranty Service and to transform the VA home loan program for veterans by building more tailored solutions to enable better outcomes. The contract is valued at up to $328M and runs for one base year, with three one-year options.

07:21 EDT Superior Group reinstates regular dividend of 10c per share - The Board of Directors today declared a regular quarterly dividend of $0.10 per share, payable August 25, 2020, to shareholders of record as of August 11, 2020 and a special dividend of $0.10 per share, payable August 25, 2020, to shareholders of record as of August 11, 2020.

07:17 EDT Garmin reports Q2 Auto segment revenue down 45% - Garmin said in its Q2 earnings release, "Revenue from the auto segment declined 46% during the second quarter, as the pandemic significantly impacted driving activity and production of new vehicles. Gross margin was 47%, and we experienced an operating loss of $10 million in the quarter. During the quarter, we launched the oversized dezl GPS truck navigators featuring large, easy-to-read HD touchscreens, industry-best load-to-dock guidance and popular truck routing for professional truck drivers. We also launched the RV 890 navigator specifically geared for the RV and camping lifestyle, with a large high-resolution touchscreen display and revamped voice assistant which simplifies overall interaction with the navigator. Looking forward, our auto segment is committed to enhancing the automotive experience through compelling aftermarket products for adventure, professional and daily drivers, and becoming a respected tier 1 supplier of innovative electronic solutions for a broad range of vehicles."

07:16 EDT Garmin reports Q2 Aviation revenue down 31% - Garmin said in its Q2 earnings release, "Revenue from the aviation segment declined 31% in the second quarter, as the pandemic negatively impacted OEM and aftermarket product categories, and the ADS-B market rapidly matured. Gross margin and operating margin were 73% and 12%, respectively. During the quarter, we received FAA certification for the Garmin Autoland system in the Piper M600, marking the beginning of a new era for general aviation safety technology. We continue to invest in additional certifications and new products that will make general aviation safer and more accessible."

07:15 EDT Garmin reports Q2 Marine revenue up 4% - Garmin said in its Q2 earnings release, "Revenue from the marine segment grew 4% in the second quarter across multiple categories led by chartplotters and Panoptix(TM) sonar technology. Gross margin and operating margin were 59% and 28%, respectively. Regulator Marine expanded its exclusive relationship with Garmin, selecting the Fusion Apollo series stereos as standard equipment on its offshore sportfishing center console boats. Also, we launched quatix(R) solar, our first marine smartwatch featuring solar charging technology. We remain focused on providing leading edge, high quality products and systems with the latest technology that our customers demand."

07:13 EDT Aaron's reports Q2 business same store revenues up 1.4%

07:12 EDT Lithia Motors announces addition of BMW of San Francisico, adds $210M in revenue - Lithia Motors announced the addition of BMW of San Francisco. BMW of San Francisco is another example of Lithia's strategy of acquiring franchises in strategic locations. The store is expected to generate $210M in revenue and joins Lithia's network of 190 physical locations nationwide, providing both in store and digital home offerings serving customers throughout the entire ownership lifecycle. This acquisition was financed using free cash flows and existing on-balance sheet capacity. "We're very pleased to announce that we have expanded our network in our Southwest Region with BMW of San Francisco," said Bryan DeBoer, Lithia Motors president and CEO. "This purchase brings our annual network revenue expansion thus far in 2020 to over $500 million annually, increasing our network density to more conveniently reach our customers."

07:11 EDT Aaron's intends to separate into two public companies - Aaron's announced that it intends to separate into two independent, publicly-traded companies: Progressive Leasing and the Aaron's Business. Both companies are expected to benefit from improved strategic focus, market-leading positions, strong free cash flow generation and well-capitalized balance sheets, enabling each to unlock substantial value creation opportunities. The separation is planned as a tax-free spin-off of Aaron's to the company's shareholders and is expected to be completed by the end of the year. "I'm proud that we have built two strong businesses, both of which are well-positioned for long-term success as independent companies," said John Robinson, President and CEO of Aaron's. "The Board and management team believe that separating Progressive and Aaron's will enhance long-term shareholder value and is the next logical step in the evolution of our organization."

07:10 EDT Shopify up 9.1% after reporting Q2 results - Shares of Shopify are up 9.1% in pre-market trading to $1,078.03 per share.

07:08 EDT Regeneron: BARDA to procure REGN-EB3 for national preparedness - Regeneron Pharmaceuticals announced that the Biomedical Advanced Research and Development Authority, part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, has entered into an agreement to procure REGN-EB3 as part of the HHS' goal of building national preparedness for public health emergencies. REGN-EB3 is Regeneron's investigational triple antibody cocktail treatment for Ebola virus infection and is currently under Priority Review by the U.S. FDA, with a target action date of October 25, 2020. Contingent on FDA approval, Regeneron expects to deliver an established number of treatment doses over the course of six years and receive compensation of approximately $10M in 2021 and an average of $67 million per year for each of the next five years.

07:08 EDT Scotts Miracle-Gro board approves special dividend of $5 per share - ScottsMiracle-Gro said its Board of Directors approved payment of a special dividend of $5 per share and increased its regular quarterly dividend by 7 percent to 62c per share. Both dividends are payable September 10 to shareholders of record on August 27.

07:04 EDT Penske estimates savings $34M in cash during Q2 by suspending dividend - Penske Automotive said in its Q2 release, "On May 13, the company announced that its Board of Directors suspended its cash dividends to help mitigate the impact of COVID-19. The company estimated that the suspension of the dividend preserved approximately $34 million in cash during the second quarter. For the six months ended June 30, 2020, the company repurchased 1,023,288 shares for $34.2 million. Approximately $170.6 million remains available to repurchase shares under the company's existing share repurchase authorization."

06:57 EDT Wabash reports Q2 backlog approximately $750M

06:49 EDT Northern Dynasty complete review of Final EIS for Pebble project - Northern Dynasty (NAK) and its 100%-owned US-based subsidiary Pebble Limited Partnership have completed a review of the Final Environmental Impact Statement, or Final EIS, for the proposed Pebble copper-gold-molybdenum project, as published by lead federal regulator the U.S. Army Corps of Engineers, or USACE, last week. Northern Dynasty President & CEO Ron Thiessen confirmed the Final EIS for the Pebble Project describes a modern mineral development project that can fully co-exist with the subsistence, commercial and recreational fishing resources of southwest Alaska, while protecting water quality, downstream flows and associated aquatic habitat. The USACE also found Pebble can make a significant socioeconomic contribution to the Bristol Bay region, its residents and communities, as well as to state and local governments. ontractor selected in early 2018. Aecom (ACM) is a firm with a history of providing regulatory compliance and other professional services associated with the development of large, complex mineral and oil and gas development projects in Alaska and the United States. Thiessen said Aecom's extensive global experience and reputation as an engineering and environmental leader adds additional credibility to the EIS findings. He said the Final EIS, published is clear that development activities proposed at Pebble would not affect the number of adult salmon returning to Bristol Bay watersheds, nor the value of the fishery.

06:34 EDT Linde starts up new ASU, nitrogen generator for customer in Taiwan - Linde announced that it has started up a new air separation unit, or ASU, and the first of three nitrogen generators, as part of a 15-year contract to supply ultra-high purity industrial gases to a electronics customer in Taiwan. Built and operated by Linde's joint venture Linde LienHwa, or LLH, the project will support a multi-billion-dollar wafer fab expansion in Tainan Science Park, Taiwan. The remaining two generators are expected to come on stream in 2021. Once completed, the ASU and the three generators will have a total combined gas capacity of over 173,000 Nm3/hr. This latest start-up builds on Linde's 35-year track record as a provider of industrial gases and gas engineering solutions with a network of plants in Taiwan. Over the past five years, LLH has invested more than $600M in its production capacities under several long-term commitments with its customers in Taiwan.

06:30 EDT Eaton backs FY20 free cash flow view $2.3B-$2.7B

06:30 EDT GE CEO says Industrial free cash flow better than expectations - Reports Industrial free cash flow of ($2.1B). GE Chairman and CEO H. Lawrence Culp, Jr. said, "The GE team remains focused on protecting the safety of our people, serving our customers and communities, and preserving our strengths, and I want to thank all of my colleagues for their tireless efforts. We had a very challenging second quarter that we met head-on, executing well operationally while we took actions to further de-risk our company. Our earnings performance was impacted by the ongoing impact of COVID-19 on our businesses, but Industrial free cash flow was better than our expectations and previously communicated range. We made faster progress on elements within our control, including our targeted cost and cash preservation actions."

06:25 EDT Winnebago announces exclusive partnership agreement Polser USA - Winnebago said in a release, "In the wake of COVID-19, the awareness and importance of protecting people operating in mobile outreach vehicles has never been greater. Winnebago Industries Specialty Vehicle Division and Polser USA have reached an exclusive partnership agreement to provide Polser USA's permanent antimicrobial coating on the interior walls of Winnebago Class A Specialty Vehicles. Research shows Polser USA's antimicrobial, or AMB, coating technology eliminates nearly all surface microorganisms within several hours. Polser's patented AMB material coats fiberglass-reinforced polyester surfaces to mechanically kill microorganisms like bacteria and viruses, and reduce discoloration, odors, and polymer breakdowns caused by microbes. The material acts like a microscopic bed of nails made from carbon nano-needles that pierce cell membranes and eliminate mutation, adaptation, or resistance to chemical solutions. Polser AMB has a broad pathogen killing spectrum, including certain strains of Influenza, Staphylococcus, Streptococcus, Salmonella, and more. Winnebago Industries' Specialty Vehicles are utilized across the country for a multitude of purposes, including mobile healthcare, education, library services, community outreach, and more. Most recently, the Specialty Vehicle Division has delivered seven mobile childhood advocacy centers to the New York Office of Child and Family Services, the nation's first zero-emission mobile surgical instrument lab to the University of California at Los Angeles Health Center, and a food truck serving lunches to disadvantaged areas to the Minnesota Vikings Foundation. Polser USA's AMB technology will be available immediately for all Class A Speciality Vehicles."

06:22 EDT Barclays CET1 ratio stands at 14.2%

06:19 EDT Owens Corning CEO says 'encouraged by the positive momentum' - "Our team continued to execute well, while adapting to dynamic market conditions and working hard to meet the needs of our customers. We've further strengthened our balance sheet and available liquidity, which enables our company to better manage uncertainties associated with the pandemic," said Chairman and CEO Brian Chambers. "I'm encouraged by the positive momentum we are beginning to see in some of our key markets and believe we are well positioned to capitalize on near-term opportunities and to execute on our longer-term growth priorities."

06:16 EDT Barclays to suspend current capital returns policy for 2020 - Barclays said in a statement: "In response to a request from the PRA, and to preserve additional capital for use in serving Barclays customers and clients through the extraordinary challenges presented by the COVID-19 pandemic, the Board agreed to cancel the 6.0p perordinary share full year 2019 dividend. The Board also decided that for 2020 Barclays would suspend itscurrent capital returns policy and accordingly will not undertake any interim ordinary share dividend payments, regulatory accruals of ordinary share dividends, or share buybacks. The Board will decide on future dividends and its capital returns policy at year-end 2020."

06:13 EDT Deutsche Bank still sees FY20 provision of credit losses 35-45bps of loans

06:11 EDT Anthem says share repurchase activity resumed in late-June - During the second quarter of 2020, the company repurchased 213 thousand shares of its common stock for $55 million, or a weighted average price of $258.77. Year to date, the company has repurchased 2.1 million shares for $584 million, or a weighted average price of $273.72. As of June 30, the company had approximately $3.2 billion of Board-approved share repurchase authorization remaining.

06:10 EDT Vale reports Q2 iron ore fines production 67.6 Mt - Vale's iron ore fines production totalled 67.6 Mt, with June production above 25 Mt, displaying strong acceleration from April and May levels, as it enters a seasonally-strong period, with lower rainfall levels. S11D reached a run-rate of 91 Mtpy in June, which is likely to improve in 2H20 towards an annual production slightly over 85 Mt. Nevertheless, the main effects that weighed on Q2 production were: (i) COVID-19 related impacts of 3.5 Mt; (ii) non-recurring events, such as long-distance conveyor belt maintenance at S11D, with a negative impact of 2.1 Mt; and (iii) the expected stoppage of Fazendao mine in February due to depletion of the licensed mining area, planned to restart operations during 3Q20, with an average monthly production of 0.4 Mt in the rest of the year.

06:08 EDT Repare Therapeutics doses first patient in Phase 1/2 clinical trial of RP-3500 - Repare Therapeutics announced the first patient has been dosed in the Phase 1/2 clinical trial of RP-3500, a potent and selective oral small molecule inhibitor of ATR for the treatment of solid tumors with specific genome instability-related genomic alterations including those in ATM gene. The multi-center trial will enroll patients with advanced solid tumors of any histology that harbor gene alterations that suggest sensitivity to ATR inhibition as discovered by Repare's proprietary SNIPRx platform. Dosing follows acceptance by the U.S. FDA of the company's investigational new drug application earlier this month.

06:04 EDT Spotify reports 138M Premium Subscribers globally at Q2-end, up 27% y/y

05:55 EDT Amazon to tout job creation, support for small businesses in antitrust hearing - Amazon CEO Jeff Bezos plans to tout the company's job creation and support for small businesses during Wednesday's antitrust hearing, according to prepared remarks released by the company. Bezos will tell the House Antitrust Subcommitee that Amazon now employs a million people and that it built an online marketplace that allows some third-party sellers to make more than $100,000 a year. He acknowledges that Amazon is "a large company" but that its sprawling scale has created more than $1 trillion of wealth for its shareholders, which include "fire, police, and school teacher pension funds." "It's not a coincidence that Amazon was born in this country," Bezos said in his prepared remarks. "More than any other place on Earth, new companies can start, grow, and thrive here in the U.S." "As I have said since my first shareholder letter in 1997, we make decisions based on the long-term value we create as we invent to meet customer needs," Bezos said. "When we're criticized for those choices, we listen and look at ourselves in the mirror. When we think our critics are right, we change. When we make mistakes, we apologize. But when you look in the mirror, assess the criticism, and still believe you're doing the right thing, no force in the world should be able to move you." Reference Link

05:52 EDT Vodafone chooses BlackBerry AtHoc for secure crisis communications offering - BlackBerry (BB) announced an expanded partnership with Vodafone (VOD) to offer BlackBerry AtHoc as its emergency alert and crisis communications solution. BlackBerry said in a release, "Greater Manchester Police and Greater Manchester Fire and Rescue Service are the first two customers who have selected BlackBerry AtHoc to deliver secure communications and real-time alerts through this partnership."

05:30 EDT Sanofi, GSK agree with UK government to supply 60M doses of COVID-19 vaccine - Sanofi and GSK have reached an agreement, subject to final contract, with the UK government for the supply of up to 60 million doses of a COVID-19 vaccine. The companies said in a release, "The vaccine candidate, developed by Sanofi in partnership with GSK, is based on the recombinant protein-based technology used by Sanofi to produce an influenza vaccine, and GSK's established pandemic adjuvant technology. Sanofi is leading the clinical development and registration of the COVID-19 vaccine and expects a Phase 1/2 study to start in September, followed by a Phase 3 study by the end of 2020. If the data are positive, regulatory approval could be achieved by the first half of 2021. In parallel, Sanofi and GSK are scaling up manufacturing of the antigen and adjuvant to produce up to one billion doses per year overall. Sanofi and GSK are committed to making the vaccine available globally. Active discussions on supply of the vaccine are ongoing with global organizations, the U.S. and the EU Commission, with France and Italy on the negotiation team. The partners plan to provide a significant portion of total worldwide available supply capacity in 2021/22 to the global initiative, "Access to COVID-19 Tools Accelerator," a global collaboration of leaders of governments, global health organizations, businesses and philanthropies to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines."